Nuoncology Labs Inc
OTC:NLAB
Nuoncology Labs Inc
Revenue
Nuoncology Labs Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nuoncology Labs Inc
OTC:NLAB
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Montrose Environmental Group Inc
NYSE:MEG
|
Revenue
$624.2m
|
CAGR 3-Years
24%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
DermTech Inc
NASDAQ:DMTK
|
Revenue
$15.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sotera Health Co
NASDAQ:SHC
|
Revenue
$1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Sera Prognostics Inc
NASDAQ:SERA
|
Revenue
$306k
|
CAGR 3-Years
117%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Spectaire Holdings Inc
NASDAQ:SPEC
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Nuoncology Labs Inc's Revenue?
Revenue
0
USD
Based on the financial report for Dec 31, 2021, Nuoncology Labs Inc's Revenue amounts to 0 USD.